Researchers at the University of California San Diego School of Medicine have developed a new magnetic resonance imaging (MRI)-based technique to help improve diagnosis of nonalcoholic fatty liver disease (NAFLD) in children. The technique is detailed in a study published Feb. 5 in Hepatology.

Prostate cancer patients with detectable prostate specific antigen (PSA) following radical prostatectomy should receive earlier, more aggressive radiation therapy treatment, according to a new study.

A group of molecules in prostate-cancer cells could one day be used to distinguish which patients with rising prostate-specific antigen (PSA) levels should be treated with radiation therapy following prostate removal.

The U.S. Food and Drug Administration (FDA) has cleared Toshiba America Medical Systems new Infinix 4D CT system to enable computed tomography (CT) imaging directly in the cath lab. It integrates an Aquilion Prime CT system and Infinix Elite cardiovascular X-ray angiography system. The Infinix 4D CT previously received FDA clearance with the Infinix Elite cardiovascular X-ray system and Aquilion One Vision Edition CT system configuration.
 
Bonn Call for Action, FDA, radiation exposure, medical imaging, update

The U.S. Food and Drug Administration (FDA) announced its latest efforts in supporting the Bonn Call for Action, an international list of priorities for radiation protection in medicine for the next decade.

Voyant Health, a Brainlab company, announced that it has received U.S. Food and Drug Administration (FDA) clearance on TraumaCad Mobile, a mobile solution for pre-operative orthopedic surgical planning and digital templating.

Virginia, prostate cancer, adjuvant radiation therapy, prostatectomy, salvage

Two new studies from the University of Virginia School of Medicine have cast doubt on the wisdom of delaying radiation treatment for prostate cancer as long as possible after the removal of the prostate. The pervading belief is that doing so helps prevent unwanted side effects.
Brainlab, ExacTrac, Versa HD, Elekta, LMU, Munich, LINAC, first

Brainlab announced first patient treatments on a fully integrated radiation oncology solution that combines ExacTrac patient positioning with the delivery precision of the Elekta Versa HD linear accelerator (LINAC). These technologies work in synergy to determine positioning and treatment accuracy for cancer patients.

The U.S. Food and Drug Administration (FDA) released an updated Mammography Quality Standards Act and Program (MQSA) Scorecard, which offers answers to the most commonly requested national statistics regarding the MQSA program. These statistics are updated on the first of each month.

Subscribe to
© Copyright Wainscot Media. All Rights Reserved.
Subscribe Now